Impact of ribociclib (RIB) dose reduction on overall...

Annals of Oncology 2020 / 09 Vol. 31

Impact of ribociclib (RIB) dose reduction on overall survival (OS) in patients (pts) with HR+/HER2− advanced breast cancer (ABC) in MONALEESA (ML) -3 and -7

De Laurentiis, M., Merino, L. de la Cruz, Hart, L., Bardia, A., Im, S-A., Sohn, J., Neven, P., Martin, M., Ji, Y., Yang, S., Hu, H., Lteif, A., Tripathy, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.433
Date:
September, 2020
File:
PDF, 101 KB
2020
Conversion to is in progress
Conversion to is failed